Comparison of repeated doses of ivermectin versus ivermectin plus albendazole for the treatment of onchocerciasis: A randomized, open-label, clinical trial

Authors

Linda Batsa Debrah, Kwame Nkrumah University of Science and Technology
Kerstin Fischer, Washington University School of Medicine in St. Louis
Gary Weil, Washington University School of Medicine in St. Louis
et al.

Journal

Clinical infectious diseases

Publication Date

8-14-2020

Volume

71

Issue

4

First Page

933

Last Page

943

Document Type

Open Access Publication

DOI

10.1093/cid/ciz889

Rights and Permissions

Linda Batsa Debrah, Ute Klarmann-Schulz, Jubin Osei-Mensah, Bettina Dubben, Kerstin Fischer, Yusif Mubarik, Nana Kwame Ayisi-Boateng, Arcangelo Ricchiuto, Rolf Fimmers, Peter Konadu, Jennifer Nadal, Barbara Gruetzmacher, Gary Weil, James W Kazura, Christopher L King, Alexander Y Debrah, Achim Hoerauf, Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial, Clinical Infectious Diseases, Volume 71, Issue 4, 15 August 2020, Pages 933–943, https://doi.org/10.1093/cid/ciz889. © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Batsa Debrah, Linda; Fischer, Kerstin; Weil, Gary; and et al., "Comparison of repeated doses of ivermectin versus ivermectin plus albendazole for the treatment of onchocerciasis: A randomized, open-label, clinical trial." Clinical infectious diseases. 71, 4. 933 - 943. (2020).
https://digitalcommons.wustl.edu/oa_4/957

Additional Links

Supplemental material is available for this article at publisher site.